Fetal Pillow Randomized Controlled Trial

September 18, 2019 updated by: Julian N Robinson, Brigham and Women's Hospital

Outcomes Following Cesarean Delivery for Failure to Progress With Use of a Fetal Pillow

The purpose of this study is to evaluate outcomes following cesarean delivery for failure to progress with the use of the Fetal Pillow. Our hypothesis is that time to delivery of the fetus is shorter with implementation of the Fetal Pillow.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Women will be enrolled from the labor floor during their labor course when there is concern for cesarean section for failure to progress in the second stage of labor. These women may be approached if they have a prolonged labor course (before they reach full dilation), when they get to full dilation and start pushing, or following an unsuccessful operative delivery. All women who meet the inclusion criteria will be approached about participation in the study on labor and delivery. The process of informed consent will happen at that time on labor and delivery. All women will be enrolled by study staff or certain physicians at Brigham and Women's Hospital who have agreed to help consent patients for this study.

Once consent is obtained, the subjects will then be randomized 1:1 into two parallel groups, the Fetal Pillow Inflated (FPI) group and the Fetal Pillow Not Inflated (FPNI) group. A random number generator will allocate the groups in blocks of ten.

The Fetal Pillows used in the study have been donated by Safe Obstetrics Systems.

Each patient will have a Fetal Pillow inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow if the patient has been randomized into the Fetal Pillow Inflated (FPI) group. In the Fetal Pillow Not Inflated (FPNI) group, the device will remain, not inflated, in the vagina. The obstetrician will therefore be blinded to the intervention. In the FPNI group the obstetrician will continue to be able to use conventional methods for delivery of a second stage arrest including hand from below and reverse breech extraction. The Fetal Pillow will be drained by the circulating nurse in the operating room following delivery with removal at the end of the procedure by the obstetrician.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02115
        • Brigham and Women's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • women age 18-50
  • term pregnancy (37- 41 6/7 weeks)
  • singleton gestation in cephalic presentation
  • fully dilated
  • both nulliparous and multiparous women
  • both spontaneous labor and labor inductions

Exclusion Criteria:

  • breech presentation
  • presence of contraindication to vaginal delivery
  • prior cesarean section
  • presence of congenital anomalies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Fetal Pillow Inflated (FPI)

A Fetal Pillow will be inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The anesthesiologist will then inflate the Fetal Pillow. The obstetrician will not be aware to inflation of Fetal Pillow

Cesarean delivery will then be performed

The circulating nurse will deflate the Fetal Pillow following delivery. The obstetrician will remove the Fetal Pillow at the end of the procedure. The obstetrician will then fill out a survey regarding the delivery.

see arm description
No Intervention: Fetal Pillow Not Inflated (FPNI)

A Fetal Pillow will be inserted vaginally by the obstetrician after catheterization of the bladder (if it has not been previously performed). Once the Fetal Pillow is in place, the woman's legs will be placed flat on the operating table. The Fetal Pillow will not be inflated.

Cesarean delivery will then be performed. The obstetrician will continue to be able to use conventional methods for delivery of a second stage arrest including hand from below and reverse breech extraction.

The circulating nurse will deflate the Fetal Pillow following delivery. The obstetrician will remove the Fetal Pillow at the end of the procedure. The obstetrician will then fill out a survey regarding the delivery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Uterine incision to delivery time
Time Frame: Assessed at time of delivery, delivery day (day 0)
Time (in seconds) from hysterotomy to delivery
Assessed at time of delivery, delivery day (day 0)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficulty of Delivery of Fetal head
Time Frame: Assessed at time of delivery, delivery day (day 0)
Score of difficulty of delivery 1-5 (1: very difficult, 5: very easy)
Assessed at time of delivery, delivery day (day 0)
Uterine extension
Time Frame: Assessed at time of delivery, delivery day (day 0)
Grading of extension 1-3
Assessed at time of delivery, delivery day (day 0)
Composite Maternal Morbidity
Time Frame: Assessed both following delivery (day 0) and at end of study period (week 4)
Blood loss, presence of blood transfusion, change in hematocrit from preop to postop day 1, temperature>100.4, ICU transfer, presence of Disseminated intravascular coagulation (DIC), readmission
Assessed both following delivery (day 0) and at end of study period (week 4)
Length of stay
Time Frame: Assessed at end of study period (week 4)
Maternal Length of stay
Assessed at end of study period (week 4)
Fetal Weight
Time Frame: Assessed at time of delivery, delivery day (day 0)
Weight of fetus at time of birth
Assessed at time of delivery, delivery day (day 0)
1 minute APGAR
Time Frame: Assessed at time of delivery, delivery day (day 0)
Assessment of the 1 minute APGAR
Assessed at time of delivery, delivery day (day 0)
5 minute APGAR
Time Frame: Assessed at time of delivery, delivery day (day 0)
Assessment of the 5 minute APGAR
Assessed at time of delivery, delivery day (day 0)
Composite Neonatal Morbidity
Time Frame: Assessed at end of study period (week 4)
Need for intubation, fetal trauma
Assessed at end of study period (week 4)
Neonatal Intensive Care Unit (NICU) Length of Stay
Time Frame: Assessed at end of study period (week 4)
Length of stay in NICU
Assessed at end of study period (week 4)
Provider Opinions
Time Frame: Assessed at end of study period (week 4)
Willingness to recommend to others based on ease of placement and removal (1-5 point scale)
Assessed at end of study period (week 4)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Julian N Robinson, MD, Brigham and Women's Hospital, Harvard Medical School, Boston MA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 13, 2018

Primary Completion (Actual)

August 1, 2019

Study Completion (Actual)

August 1, 2019

Study Registration Dates

First Submitted

September 8, 2017

First Submitted That Met QC Criteria

November 13, 2017

First Posted (Actual)

November 17, 2017

Study Record Updates

Last Update Posted (Actual)

September 19, 2019

Last Update Submitted That Met QC Criteria

September 18, 2019

Last Verified

September 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 2017P001986

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Labor Complication

Clinical Trials on Fetal Pillow

3
Subscribe